Transcranial laser therapy and infarct volume

Stroke

Volumn 44, Issue 7, 2013, Pages 2025-2027

  Kasner, Scott E ^a   Rose, David Z ^a   Skokan, Alexander ^a   Walker, Michael G ^b,c   Shi, Jing ^c   Streeter, Jackson ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Walker Bioscience   (United States)

^d Banyan Cio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALBERT STROKE PROGRAM EARLY CT SCORE; APHASIA; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL HEALTH ORGANIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SHAM PROCEDURE; TRANSCRANIAL LASER THERAPY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; STROKE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84879926871     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.000870     Document Type: Article

References (8)

1. Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, et al. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke. 2007;38:1843-1849
2. Zivin JA, Albers GW, Bornstein N, Chippendale T, Dahlof B, Devlin T, et al; NeuroThera Effectiveness and Safety Trial-2 Investigators. Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke. 2009;40:1359-1364
3. NEST Investigators. Transcranial laser therapy for acute ischemic stroke: a pooled analysis of NEST-1 and NEST-2. Int J Stroke. February 2, 2012. doi: 10.1111/j.1747-4949.2011.00754.x. Available at: http://onlinelibrary. wiley.com/doi/10.1111/j.1747-4949.2011.00754.x/full.
4. Carnevalli CM, Soares CP, Zngaro RA, Pinheiro AL, Silva NS. Laser light prevents apoptosis in Cho K-1 cell line. J Clin Laser Med Surg. 2003;21:193-196
5. Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol. 2001;22:1534-1542
6. Wassenaar EB, Van den Brand JG. Reliability of near-infrared spectroscopy in people with dark skin pigmentation. J Clin Monit Comput. 2005;19:195-199
7. Saver JL, Johnston KC, Homer D, Wityk R, Koroshetz W, Truskowski LL, et al. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. Stroke. 1999;30:293-298
8. Vogt G, Laage R, Shuaib A, Schneider A; VISTA Collaboration. Initial lesion volume is an independent predictor of clinical stroke outcome at day 90: an analysis of the Virtual International Stroke Trials Archive (VISTA) database. Stroke. 2012;43:1266-1272.